177 related articles for article (PubMed ID: 23899356)
1. Ciprofloxacin prophylaxis in high risk neutropenic patients: effects on outcomes, antimicrobial therapy and resistance.
Garnica M; Nouér SA; Pellegrino FL; Moreira BM; Maiolino A; Nucci M
BMC Infect Dis; 2013 Jul; 13():356. PubMed ID: 23899356
[TBL] [Abstract][Full Text] [Related]
2. Ciprofloxacin prophylaxis in patients with acute leukemia and granulocytopenia in an area with a high prevalence of ciprofloxacin-resistant Escherichia coli.
Gomez L; Garau J; Estrada C; Marquez M; Dalmau D; Xercavins M; Martí JM; Estany C
Cancer; 2003 Jan; 97(2):419-24. PubMed ID: 12518366
[TBL] [Abstract][Full Text] [Related]
3. Antibiotic rotation for febrile neutropenic patients with hematological malignancies: clinical significance of antibiotic heterogeneity.
Chong Y; Shimoda S; Yakushiji H; Ito Y; Miyamoto T; Kamimura T; Shimono N; Akashi K
PLoS One; 2013; 8(1):e54190. PubMed ID: 23372683
[TBL] [Abstract][Full Text] [Related]
4. Escherichia coli and Klebsiella pneumoniae bacteremia in patients with neutropenic fever: factors associated with extended-spectrum β-lactamase production and its impact on outcome.
Kim SH; Kwon JC; Choi SM; Lee DG; Park SH; Choi JH; Yoo JH; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Cho SG; Kim DW; Lee JW; Min WS
Ann Hematol; 2013 Apr; 92(4):533-41. PubMed ID: 23161391
[TBL] [Abstract][Full Text] [Related]
5. Quinolone resistance in neutropenic patients: the effect of prescribing policy in the UK and Pakistan.
Zaidi Y; Hastings M; Murray J; Hassan R; Kurshid M; Mahendra P
Clin Lab Haematol; 2001 Feb; 23(1):39-42. PubMed ID: 11422229
[TBL] [Abstract][Full Text] [Related]
6. Ciprofloxacin prophylaxis delays initiation of broad-spectrum antibiotic therapy and reduces the overall use of antimicrobial agents during induction therapy for acute leukaemia: A single-centre study.
Hallböök H; Lidström AK; Pauksens K
Infect Dis (Lond); 2016; 48(6):443-8. PubMed ID: 27030917
[TBL] [Abstract][Full Text] [Related]
7. Moxifloxacin versus levofloxacin or ciprofloxacin prophylaxis in acute myeloid leukemia patients receiving chemotherapy.
Przybylski DJ; Reeves DJ
Support Care Cancer; 2017 Dec; 25(12):3715-3721. PubMed ID: 28660351
[TBL] [Abstract][Full Text] [Related]
8. Extended follow-up of an antibiotic cycling program for the management of febrile neutropenia in a hematologic malignancy and hematopoietic cell transplantation unit.
Cumpston A; Craig M; Hamadani M; Abraham J; Hobbs GR; Sarwari AR
Transpl Infect Dis; 2013 Apr; 15(2):142-9. PubMed ID: 23279656
[TBL] [Abstract][Full Text] [Related]
9. Use of fluoroquinolones as prophylactic agents in patients with neutropenia.
Patrick CC
Pediatr Infect Dis J; 1997 Jan; 16(1):135-9; discussion 160-2. PubMed ID: 9002124
[TBL] [Abstract][Full Text] [Related]
10. Clinical and microbiological impact of discontinuation of fluoroquinolone prophylaxis in patients with prolonged profound neutropenia.
Verlinden A; Jansens H; Goossens H; van de Velde AL; Schroyens WA; Berneman ZN; Gadisseur AP
Eur J Haematol; 2014 Oct; 93(4):302-8. PubMed ID: 24750350
[TBL] [Abstract][Full Text] [Related]
11. Rifampin does not improve the efficacy of quinolone antibacterial prophylaxis in neutropenic cancer patients: results of a randomized clinical trial.
Gomez-Martin C; Solá C; Hornedo J; Perea S; Lumbreras C; Valentí V; Arcediano A; Rodriguez M; Salazar R; Cortés-Funes H; Hidalgo M
J Clin Oncol; 2000 May; 18(10):2126-34. PubMed ID: 10811678
[TBL] [Abstract][Full Text] [Related]
12. Ciprofloxacin versus colistin prophylaxis during neutropenia in acute myeloid leukemia: two parallel patient cohorts treated in a single center.
Pohlen M; Marx J; Mellmann A; Becker K; Mesters RM; Mikesch JH; Schliemann C; Lenz G; Müller-Tidow C; Büchner T; Krug U; Stelljes M; Karch H; Peters G; Gerth HU; Görlich D; Berdel WE
Haematologica; 2016 Oct; 101(10):1208-1215. PubMed ID: 27470601
[TBL] [Abstract][Full Text] [Related]
13. Ciprofloxacin plus piperacillin compared with tobramycin plus piperacillin as empirical therapy in febrile neutropenic patients. A randomized, double-blind trial.
Peacock JE; Herrington DA; Wade JC; Lazarus HM; Reed MD; Sinclair JW; Haverstock DC; Kowalsky SF; Hurd DD; Cushing DA; Harman CP; Donowitz GR
Ann Intern Med; 2002 Jul; 137(2):77-87. PubMed ID: 12118962
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology of bloodstream infections in patients with acute myeloid leukemia undergoing levofloxacin prophylaxis.
De Rosa FG; Motta I; Audisio E; Frairia C; Busca A; Di Perri G; Marmont F
BMC Infect Dis; 2013 Dec; 13():563. PubMed ID: 24289496
[TBL] [Abstract][Full Text] [Related]
15. Fluoroquinolone resistance of Escherichia coli at a cancer center: epidemiologic evolution and effects of discontinuing prophylactic fluoroquinolone use in neutropenic patients with leukemia.
Kern WV; Klose K; Jellen-Ritter AS; Oethinger M; Bohnert J; Kern P; Reuter S; von Baum H; Marre R
Eur J Clin Microbiol Infect Dis; 2005 Feb; 24(2):111-8. PubMed ID: 15714332
[TBL] [Abstract][Full Text] [Related]
16. Effect of quinolone prophylaxis in afebrile neutropenic patients on microbial resistance: systematic review and meta-analysis.
Gafter-Gvili A; Paul M; Fraser A; Leibovici L
J Antimicrob Chemother; 2007 Jan; 59(1):5-22. PubMed ID: 17077101
[TBL] [Abstract][Full Text] [Related]
17. Prophylactic antibiotics eliminate bacteremia and allow safe outpatient management following high-dose chemotherapy and autologous stem cell rescue.
Meisenberg B; Gollard R; Brehm T; McMillan R; Miller W
Support Care Cancer; 1996 Sep; 4(5):364-9. PubMed ID: 8883230
[TBL] [Abstract][Full Text] [Related]
18. Effect of discontinuing prophylaxis with norfloxacin in patients with hematologic malignancies and severe neutropenia. A matched case-control study of the effect on infectious morbidity.
Martino R; Subira M; Altés A; López R; Sureda A; Domingo-Albós A; Pericas R; Brunet S
Acta Haematol; 1998; 99(4):206-11. PubMed ID: 9644298
[TBL] [Abstract][Full Text] [Related]
19. Oral ciprofloxacin plus colistin: prophylaxis against bacterial infection in neutropenic patients. A strategy for the prevention of emergence of antimicrobial resistance.
Prentice HG; Hann IM; Nazareth B; Paterson P; Bhamra A; Kibbler CC
Br J Haematol; 2001 Oct; 115(1):46-52. PubMed ID: 11722408
[TBL] [Abstract][Full Text] [Related]
20. Colonization With Levofloxacin-resistant Extended-spectrum β-Lactamase-producing Enterobacteriaceae and Risk of Bacteremia in Hematopoietic Stem Cell Transplant Recipients.
Satlin MJ; Chavda KD; Baker TM; Chen L; Shashkina E; Soave R; Small CB; Jacobs SE; Shore TB; van Besien K; Westblade LF; Schuetz AN; Fowler VG; Jenkins SG; Walsh TJ; Kreiswirth BN
Clin Infect Dis; 2018 Nov; 67(11):1720-1728. PubMed ID: 29701766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
